HOME >> BIOLOGY >> NEWS
Pioneering researcher Dr. Kenneth Lyons Jones receives genetics award from March of Dimes

WHITE PLAINS, N.Y., MARCH 16, 2007 -- Kenneth Lyons Jones, M.D., the renowned pediatrician and birth defects researcher who was one of two doctors who identified fetal alcohol syndrome (FAS), will receive the 2007 March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.

The award will be presented to Dr. Jones on March 23 at the Annual Clinical Genetics Meeting of the American College of Medical Genetics in Nashville, Tennessee. Michael Katz, M.D., senior vice president for Research and Global Programs of the March of Dimes, will preside over the ceremony.

Dr. Jones is Chief of the Division of Dysmorphology/Teratology in the Department of Pediatrics at the University of California, San Diego (UCSD). He has been active in research, teaching, clinical work, and public service for nearly 40 years. Dr. Jones was also awarded a March of Dimes grant for organizing an annual seminar in clinical teratology.

Dr. Jones research has focused on dysmorphology, the study of birth defects, particularly those affecting the anatomy of the individual; identifying the mechanisms of normal and abnormal fetal development; and the recognition of new human teratogens (birth defects-causing agents). He is the author of more than 400 publications in scientific journals, as well as several books. His book, Smiths Recognizable Patterns of Human Malformation, is the reference used by health care professions to assist in the diagnosis and management of individuals with birth defects and genetic conditions.

Among Dr. Jones many accomplishments, the most famous by now is his coining of the term fetal alcohol syndrome, along with David W. Smith, M.D., to define the distinct cluster of birth defects seen exclusively in the babies of women who used alcohol during pregnancy. In 1973, the two published their finding that alcohol was a teratogen in the British journal Lancet*.

Dr.
'"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
16-Mar-2007


Page: 1 2

Related biology news :

1. Pioneering research on sleeping sickness wins MERIAL Award for Parasitology
2. Pioneering approach to wastewater treatment earns Stanford engineer the 2007 Stockholm Water Prize
3. Pioneering research into health benefits of beauty treatment
4. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
5. Pioneering research on ALS muscle disease rewarded
6. Pioneering PET/CT research widens applications of imaging for diabetic foot
7. Innovative tagging technique may help researchers better protect fish stocks
8. Penn researchers discover how key protein stops inflammation
9. ASU researchers partner with UOP to make biofuel for military jets a reality
10. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
11. Penn researchers discover pathway that eliminates genetic defects in red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, ... company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... solutions in complex indoor environments, announced today that Derek Fournier has been appointed ... of Chairman of the Board, effective immediately. , “DeCurtis Corporation has been ...
(Date:6/23/2020)... NEW YORK (PRWEB) , ... June 22, 2020 ... ... profiling its lead glutamine antagonist, DRP-104, will be presented June 22-24 during the ... anti-cancer effects of DRP-104; and, the other profiles the potent, consistent single agent ...
(Date:6/19/2020)... ... , ... The Vitaspace project was founded by the famous Russian ... life and find a way (medicine or technology) that will help to preserve youth, ... scientists from all over the world, doctors, and all people who care. , The ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... Phase I of a Small Business Innovation Research (SBIR) program funded by the ... Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer ...
Breaking Biology Technology:
Cached News: